Lilly(LLY) - 2023 Q4 - Earnings Call Transcript

Eli Lilly and Co (NYSE:LLY) Q4 2024 Earnings Conference Call February 6, 2024 10:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - EVP & CFO Daniel Skovronsky - Chief Scientific Officer and President of Lilly Immunology Ilya Yuffa - EVP of Eli Lilly and Company and President of Lilly International Patrik Jonsson - President of Lilly Diabetes and obesity and Lilly U.S.A Conference Call Participants Terence Flynn - Morgan Stanley Christopher Schott - ...